The effects of non-thermal atmospheric pressure plasma irradiation on expression levels of matrix metalloproteinases in benign melanocytic tumors in RET-transgenic mice

European Journal of Dermatology

Volumn 24, Issue 3, 2014, Pages 392-394

  Iida, Machiko ^a,b   Yajima, Ichiro ^a,b   Ohgami, Nobutaka ^a   Tamura, Haruka ^a   Takeda, Kozue ^a   Ichihara, Sahoko ^b   Hori, Masaru ^c   Kato, Masashi ^a,b  

^a CHUBU UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MATRIX METALLOPROTEINASE; PLASMA GAS; PROTEIN RET; RET PROTEIN, MOUSE;

ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; MOUSE; PIGMENTED NEVUS; PLASMA GAS; RADIATION RESPONSE; SKIN TUMOR; TRANSGENIC MOUSE;

ANIMALS; MATRIX METALLOPROTEINASES; MICE; MICE, TRANSGENIC; NEVUS, PIGMENTED; PLASMA GASES; PROTO-ONCOGENE PROTEINS C-RET; SKIN NEOPLASMS;

EID: 84905678553     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2014.2330     Document Type: Letter

References (10)

1. Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatol Clin 2002; 20: 607-16.
2. Thang ND, Yajima I, Nakagawa K, et al. A novel hairless mouse model for malignant melanoma. J Dermatol Sci 2012; 65: 207-12.
3. Kato M, Takahashi M, Akhand AA, et al. Transgenic mouse model for skin malignant melanoma. Oncogene 1998; 17: 1885-8.
4. Overall CM, López-Otín C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002; 2: 657-72.
5. Candrea E, Senila S, Tatomir C, Cosgarea R. Active and inactive forms of matrix metalloproteinases 2 and 9 in cutaneous melanoma. Int J Dermatol 2012 Oct 5. doi: 10.1111/j.1365-4632.2012.05772.x. [Epub ahead of print].
6. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001; 107: 789-800.
7. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
8. Iseki S, Nakamura K, Hayashi M, et al. Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma. Appl Phys Lett 2012; 100: 113702-4.
9. Tanaka H, Mizuno M, Ishikawa K, et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by downregulating a survival signaling molecule, AKT kinase. Plasma Med 2011; 1: 265-77
10. Ohshima Y, Yajima I, Takeda K, et al. c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines. PLoS One 2010; 5: e10279.